Jennifer Sherr, MD, Pediatric Endocrinology, New Haven, CT, Yale-New Haven Hospital

JenniferLynnSherrMDPhD

Pediatric Endocrinology New Haven, CT

Pediatric Diabetes Endocrinology

Associate Professor Pediatrics, Yale University School of Medicine

Dr. Sherr is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sherr's full profile

Already have an account?

Education & Training

  • Yale Graduate School of Arts and SciencesOTHER_TRAINING
  • Yale-New Haven Hospital
    Yale-New Haven HospitalFELLOWSHIP
  • Yale-New Haven Hospital
    Yale-New Haven HospitalRESIDENCY
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolMEDICAL_SCHOOL
  • Rutgers CollegeOTHER_TRAINING

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2006 - 2021
  • American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

  • Young Physician Scientist Award American Society for Clinical Investigation, 2013
  • Young Investigator Travel Grant Award American Diabetes Association, 2012
  • Translational Science Meeting/Scholar Abstract Award 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Closing the Loop on Managing Youth with Type 1 Diabetes: Children Are Not Just Small Adults  
    Jennifer Sherr, MD, Diabetes Care
  • New generation diabetes management: glucose sensor -augmented insulin pump therapy  
    Cengiz E, Sherr JL, Weinzimer SA, Tamborlane WV, Expert Reviews of Medical Devices, 1/1/2011
  • Practical Aspects of Sensor Augmented Pump Therapy with The Medtronic Paradigm Real Time and Guardian Real Time Systems: The Experience of the Yale Children’s Diabete...  
    Ives B, Sikes K, Sherr JL, Urban A, Stephenson K, Tamborlane WV, Infusystems USA, 1/1/2009

Books/Book Chapters

Abstracts/Posters

  • Effect of 2-Hr Suspensions of Basal Insulin in Elevating Nighttime Glucose Concentrations
    Sherr JL, Palau-Collazo MM, Carria LR, Steffen AT, Zgorski M, Weyman K, Tichy E, Michaud C, Cegniz E, Tamborlane WV, Weinzimer SA, America Diabetes Association, Chicago, 1/1/2013
  • Acute Metabolic Effects of GLP-1 Analogue in Type 1 Diabetes
    Ghazi T, Rink L, Sherr JL, Herold KC, America Diabetes Association, Chicago, 1/1/2013
  • Glucose Lowering Effects of Pre-Meal Pramlinitide During Closed-Loop Insulin Delivery is Associated with Lower Plasma Glucagon Levels and Reduced Insulin Requirements
    Palau-Collazo M, Sherr JL, Carria LR, Cengiz E, Roy A, Tamborlane WV, Tichy EM, Weyman K, Weinzimer SA, America Diabetes Association, Chicago, 1/1/2013
  • Join now to see all

Lectures

  • Diabetic Ketoacidosis 
    New Haven, CT - 1/1/2013
  • Closed Loop Technologies 
    1/1/2013
  • Update on Diabetes Management 
    1/1/2011
  • Join now to see all

Other

  • 15-year-old boy with confusion: A teenager is brought for evaluation after waking with altered mental status 
    Sherr J, Lord K, Tamborlane WV, Weinzimer SA, Contemporary Pediatrics
    1/1/2010

Authored Content

  • ADA 2018: Dr. Jennifer Sherr on Closed-Loop Systems for Type 1 Diabetes in YouthJuly 2018
  • ADA 2018: Dr. Jennifer Sherr on Closed-Loop Systems for Type 1 Diabetes in YouthJuly 2018
  • ADA 2018: Dr. Jennifer Sherr on Closed-Loop Systems for Type 1 Diabetes in YouthJuly 2018

Press Mentions

  • Nature Medicine Publishes Results Reporting Equal Clinical Outcome When Using the DreaMed Advisor® Compared with Physicians from Specialized Academic Diabetes Centers
    Nature Medicine Publishes Results Reporting Equal Clinical Outcome When Using the DreaMed Advisor® Compared with Physicians from Specialized Academic Diabetes CentersSeptember 09, 2020
  • A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm
    A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES ParadigmMay 29, 2019
  • Insulet’s Omnipod® Horizon™ Hybrid Closed-Loop System Improves Glycemic Control in Patients as Young as Two Years Old with Type 1 Diabetes
    Insulet’s Omnipod® Horizon™ Hybrid Closed-Loop System Improves Glycemic Control in Patients as Young as Two Years Old with Type 1 DiabetesFebruary 24, 2020
  • Join now to see all

Hospital Affiliations